Ridaforolimus
CAS: 572924-54-0
Ref. TM-T6334
5mg | 55,00 € | ||
10mg | 88,00 € | ||
25mg | 159,00 € | ||
50mg | 278,00 € | ||
1ml*10 (DMSO) | 92,00 € |
Información del producto
- AP23573, Deforolimus, MK-8669
- 42-(Dimethylphosphinate)rapamycin
- Ap 2357
- Ap 23573
- Mk 8669
- Rapamycin, 42-(dimethylphosphinate)
Ridaforolimus (AP23573) is a small molecule and non-prodrug analogue of the lipophilic macrolide antibiotic rapamycin with potential antitumor activity. Ridaforolimus binds to and inhibits the mammalian target of rapamycin (mTOR), which may result in cell cycle arrest and, consequently, the inhibition of tumor cell growth and proliferation. Upregulated in some tumors, mTOR is a serine/threonine kinase involved in regulating cellular proliferation, motility, and survival that is located downstream of the PI3K/Akt signaling pathway.
Propiedades químicas
Consulta técnica sobre: TM-T6334 Ridaforolimus
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.